NOVAGENIX BIOANALYTICAL DRUG

NOVAGENIX BIOANALYTICAL DRUG is neither a factory nor a trader. It is a Contract Research Organization (CRO) and an R&D center. It provides specialized services to pharmaceutical companies rather than manufacturing drugs or trading them.

Company Introduction:

NOVAGENIX BIOANALYTICAL DRUG is a Turkish-based Contract Research Organization (CRO) and an advanced Bioanalytical Research and Development (R&D) Center. The company specializes in providing comprehensive bioanalytical services and clinical research support for the pharmaceutical industry.

NOVAGENIX operates GLP (Good Laboratory Practice) certified laboratories, enabling it to conduct high-quality studies essential for drug development and regulatory submissions. Its core services include:

Bioequivalence (BE) and Biosimilarity Studies: These studies assess the comparative bioavailability of drug products.

Pharmacokinetic (PK) and Pharmacodynamic (PD) Studies: Investigating how drugs move through and affect the body.

Method Development and Validation: Establishing and validating analytical methods for drug quantification in biological matrices.

Clinical Research: Supporting various phases of clinical trials.

Drug Development Support: Offering expertise from early-stage development to post-marketing studies.

The company serves as a crucial partner for pharmaceutical manufacturers, helping them navigate the complex stages of drug development, ensuring scientific rigor, and facilitating compliance with international regulatory standards. Its focus is on generating reliable scientific data to support the safety and efficacy of new and generic drug products.

Novagenix Bioanalytical Drug, located in Turkey, is primarily a Contract Research Organization (CRO) specializing in bioanalytical services for the pharmaceutical and biotechnology industries. They do not typically produce or sell physical drug products. Instead, they provide specialized analytical services and solutions to support drug discovery, development, and regulatory submissions.

Their main service offerings include:

Bioanalytical Method Development and Validation

Pharmacokinetic (PK) and Toxicokinetic (TK) Sample Analysis

Bioequivalence (BE) Studies Support

Drug-Drug Interaction (DDI) Studies Support

Biomarker Analysis

Analysis of Small Molecules and Large Molecules (Biologics)

Metabolite Identification and Quantification

Impurity Profiling and Analysis

In Vitro ADME Studies

Consultancy in Bioanalysis and Regulatory Affairs